Clinical Trial Update: An Open Label Study That Will Test Safety and Efficacy of RZL-012 Injection Into the Submental Fat in Chinese vs. Non-Chinese Subjects. [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 trial assessing safety and efficacy of RZL-012 injected into submental fat in Chinese and non-Chinese subjects; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• RZL-012

Snippet

Sponsor: Raziel Therapeutics Ltd. | Conditions: Submental Fat | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-19